Dr. Oz Assists as Drug Executive Collapses During Oval Office Briefing
During a press conference in the Oval Office, President Donald Trump was announcing an agreement with major drugmakers to lower the cost of obesity medications when an unexpected incident occurred.
The Incident
While Eli Lilly’s CEO, David Ricks, was speaking, Novo Nordisk’s executive Gordon Findlay suddenly collapsed. Ricks stopped mid-sentence and asked,
“Are you okay? Gordon, are you okay?”
As Findlay fell to his knees, Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly came to his aid.
Response and Aftermath
President Trump, along with other attendees, observed the emergency as reporters were escorted from the room. Health and Human Services Secretary was also present during the event.
About thirty minutes later, the briefing resumed, and President Trump provided an update on Findlay’s condition, confirming that he was receiving medical attention and recovering.
The Policy Announcement
The purpose of the event was to present a new deal between the administration, Eli Lilly, and Novo Nordisk to broaden access and lower prices for the obesity medications Zepbound and Wegovy.
Key Figures Present
- President Donald Trump
- Dr. Mehmet Oz, Administrator for CMS
- David Ricks, CEO of Eli Lilly
- Gordon Findlay, Global Brand Director of Novo Nordisk
- Health and Human Services Secretary
Author's Summary: During a White House event on drug pricing, Dr. Mehmet Oz assisted Novo Nordisk’s Gordon Findlay after his collapse as President Trump announced a major deal on obesity treatment affordability.